Centrica PLC (GB:CNA)
LSE:CNA
Want to see GB:CNA full AI Analyst Report?
Top Page
Centrica
(LSE:CNA)
Select Model
Select Model
Rating:59Neutral
Price Target:
217.00 p
▲(9.93% Upside)
Action:ReiteratedDate:02/21/26
Overall score is driven primarily by mid-tier financial performance: strong revenue momentum and consistently positive free cash flow are offset by volatile bottom-line results (net loss in 2025) and a balance sheet that remains only moderately stable. Technicals are mildly supportive with the stock holding above key longer-term moving averages and neutral momentum. Valuation is reasonable with a moderate P/E and dividend yield.
Positive Factors
Diversified business model (retail, services, upstream)
Centrica's mix of retail supply, subscription-style services (e.g., British Gas), and upstream/trading creates multiple, structurally different cash streams. This reduces reliance on any single segment, supports cross-selling, and improves resilience versus peers over a 2–6 month horizon.
Negative Factors
Volatile earnings quality and net income swings
Large swings in reported net income signal earnings volatility driven by commodity, trading and one-off items. This undermines predictability for investors and management planning, complicates capital allocation and can pressure dividends or reinvestment during weaker periods.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified business model (retail, services, upstream)
Centrica's mix of retail supply, subscription-style services (e.g., British Gas), and upstream/trading creates multiple, structurally different cash streams. This reduces reliance on any single segment, supports cross-selling, and improves resilience versus peers over a 2–6 month horizon.
Read all positive factors
Centrica (CNA) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£9.55B
Dividend Yield2.86%
Average Volume (3M)20.81M
Price to Earnings (P/E)―
Beta (1Y)0.87
Revenue Growth-4.82%
EPS Growth-123.58%
CountryUK
Employees21,038
SectorUtilities
Sector Strength65
IndustryIndependent Power Producers
Share Statistics
EPS (TTM)0.04
Shares Outstanding4,619,269,000
10 Day Avg. Volume17,197,652
30 Day Avg. Volume20,808,888
Financial Highlights & Ratios
PEG Ratio1.07
Price to Book (P/B)2.63
Price to Sales (P/S)0.42
P/FCF Ratio25.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£225.00Price Target Upside13.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)0.12
Revenue Forecast (FY)£21.63B
Centrica Business Overview & Revenue Model
Company Description
Centrica plc operates as an integrated energy company in the United Kingdom, Ireland, Norway, North America, and internationally. The company operates through British Gas Services & Solutions, British Gas Energy, Centrica Business Solutions, Bord ...
How the Company Makes Money
Centrica makes money primarily through a combination of (1) retail energy supply margins, (2) service and solutions fees, and (3) upstream/market activities (production, generation, trading and optimization). (1) Retail energy supply: Centrica sel...
Centrica Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
52
Neutral
Cash Flow
60
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 19.49B | 19.91B | 26.46B | 23.74B | 14.74B |
| Gross Profit | 7.54B | 4.09B | -1.70B | 9.75B | 1.41B |
| EBITDA | 5.53B | 2.42B | 7.30B | 410.00M | 721.00M |
| Net Income | -72.00M | 1.33B | 3.93B | -782.00M | 586.00M |
Balance Sheet | |||||
| Total Assets | 15.41B | 18.73B | 21.37B | 29.04B | 27.09B |
| Cash, Cash Equivalents and Short-Term Investments | 4.31B | 6.22B | 6.85B | 4.84B | 5.06B |
| Total Debt | 3.05B | 3.51B | 4.10B | 3.96B | 4.58B |
| Total Liabilities | 11.92B | 13.92B | 17.13B | 27.76B | 24.34B |
| Stockholders Equity | 3.08B | 4.42B | 3.88B | 1.02B | 2.37B |
Cash Flow | |||||
| Free Cash Flow | 322.00M | 733.00M | 2.42B | 943.00M | 1.19B |
| Operating Cash Flow | 876.00M | 1.15B | 2.75B | 1.31B | 1.61B |
| Investing Cash Flow | -1.05B | 493.00M | 115.00M | -566.00M | 2.26B |
| Financing Cash Flow | -1.22B | -1.55B | -1.41B | -917.00M | -938.00M |
Centrica Technical Analysis
Neutral
197.40
Price Trends
197.99
Negative
185.05
Positive
173.55
Positive
Market Momentum
2.84
Positive
41.17
Neutral
13.54
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CNA, the sentiment is Neutral. The current price of 197.4 is below the 20-day moving average (MA) of 205.70, below the 50-day MA of 197.99, and above the 200-day MA of 173.55, indicating a neutral trend. The MACD of 2.84 indicates Positive momentum. The RSI at 41.17 is Neutral, neither overbought nor oversold. The STOCH value of 13.54 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:CNA.
Centrica Peers Comparison
UnderperformOutperform
Sector (66)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £64.36B | 21.31 | 7.66% | 4.15% | -9.52% | 35.74% | |
74 Outperform | £32.65B | 16.49 | 7.09% | 2.98% | 1.78% | -50.72% | |
69 Neutral | £2.92B | 0.40 | 3.94% | 2.78% | -19.04% | -34.52% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | £1.07B | 21.07 | 27.40% | 7.01% | 1.71% | -12.49% | |
59 Neutral | £9.55B | -112.68 | 1.68% | 2.86% | -4.82% | -123.58% | |
58 Neutral | £21.68M | -1.13 | -68.06% | ― | -60.76% | -230.39% |
* Utilities Sector Average
GB:CNA
Centrica
197.40
54.02
37.68%
GB:AMP
SIMEC Atlantis Energy
3.00
0.60
25.00%
GB:DRX
Drax Group plc
839.60
287.00
51.94%
GB:SSE
SSE
2,469.50
881.30
55.49%
GB:TEP
Telecom Plus
1,372.00
-342.09
-19.96%
GB:NG
National Grid
1,274.80
228.31
21.82%
Centrica Corporate Events
Regulatory Filings and Compliance
Centrica Executives Acquire Shares Under Company Incentive Plan
Neutral
Apr 13, 2026
Centrica has disclosed routine share dealings by executive directors Christopher O’Shea and Russell O’Brien under the company’s Share Incentive Plan. The transactions, administered by Equiniti, involved the acquisition of small v...
Regulatory Filings and Compliance
Centrica Confirms Total Voting Rights and Share Capital Structure
Neutral
Apr 1, 2026
Centrica has confirmed that as of 31 March 2026 its issued share capital stands at 5,064,902,964 ordinary shares, of which 445,633,930 are held in treasury and 4,619,269,034 carry one vote each. The disclosed voting share figure serves as the key ...
Regulatory Filings and ComplianceShareholder Meetings
Centrica Sets May Date and Hybrid Format for 2026 AGM
Neutral
Mar 31, 2026
Centrica has released the Notice of its 2026 Annual General Meeting, following the earlier digital publication of its 2025 Annual Report and Accounts in February. The AGM notice and proxy form have been submitted to the UK regulator’s Nation...
Other
Centrica Non-Executive Directors Boost Holdings Through Share Purchase Agreements
Positive
Mar 25, 2026
Centrica has disclosed director share dealings, with non-executive directors Frank Mastiaux and Sue Whalley acquiring ordinary shares under existing share purchase agreements with the company. The transactions, executed on the London Stock Exchang...
Business Operations and StrategyExecutive/Board Changes
Centrica Executives Receive Shares Under All-Employee Incentive Plan
Positive
Mar 23, 2026
Centrica has disclosed that executive directors Chris O’Shea and Russell O’Brien have each received an allocation of 385 ordinary shares under the company’s all-employee Share Incentive Plan. The awards, made as part of a Free Sh...
Executive/Board ChangesRegulatory Filings and Compliance
Centrica Executives Retain Shares After Incentive Awards Vest
Neutral
Mar 23, 2026
Centrica has disclosed a series of share transactions involving chief executive Chris O’Shea and fellow executive director Russell O’Brien, following the release and vesting of awards granted under the company’s Annual Incentive ...
Executive/Board Changes
Centrica grants long-term share awards and deferred incentive shares to top executives
Neutral
Mar 23, 2026
Centrica has granted new Restricted Share Plan awards to executive directors Chris O’Shea and Russell O’Brien under its Long Term Incentive Plan, with the number of shares determined using an average price of £2.086 and subject to...
Regulatory Filings and Compliance
Centrica Executives Acquire Shares Under Incentive Plan
Neutral
Mar 11, 2026
Centrica has disclosed that executive directors Christopher O’Shea and Russell O’Brien each acquired ordinary shares under the company’s Share Incentive Plan, administered by Equiniti. The transactions, involving small purchases ...
Regulatory Filings and Compliance
Centrica Updates Market on Total Voting Rights and Share Capital
Neutral
Mar 2, 2026
Centrica has reported that, as of 28 February 2026, its issued share capital totals 5,064,902,964 ordinary shares, of which 459,860,617 are held in treasury. This leaves 4,605,042,347 shares in circulation carrying one vote each, a key reference f...
Other
Centrica Directors Increase Holdings Through Share Purchase Agreements
Positive
Feb 25, 2026
Centrica has disclosed that non-executive directors Frank Mastiaux and Sue Whalley have acquired ordinary shares in the company under their existing share purchase agreements. The transactions, executed on 25 February 2026 on the London Stock Exch...
Financial DisclosuresRegulatory Filings and Compliance
Centrica Files 2025 Annual Report and Confirms Full Regulatory Disclosures
Positive
Feb 19, 2026
Centrica has published its 2025 Annual Report for the year ended 31 December 2025 on its website and submitted the document to the UK Financial Conduct Authority’s National Storage Mechanism for public inspection. The report contains the ful...
Executive/Board Changes
Centrica Announces Board Succession as Remuneration Chair to Step Down
Neutral
Feb 19, 2026
Centrica has announced that Non-Executive Director Carol Arrowsmith, who also chairs the Remuneration Committee, will step down from the board at the conclusion of the company’s 2026 AGM on 7 May, after nearly six years of service. The board...
DividendsFinancial DisclosuresRegulatory Filings and ComplianceShareholder Meetings
Centrica Lifts 2025 Dividend as Preliminary Results Released
Positive
Feb 19, 2026
Centrica has published its preliminary results for the year ended 31 December 2025 and made the full report available via its website and the UK financial regulator’s National Storage Mechanism. The company will present these 2025 preliminar...
Regulatory Filings and Compliance
Centrica Executives Add Shares Through Incentive Plan
Positive
Feb 11, 2026
Centrica has disclosed that executive directors Christopher O’Shea and Russell O’Brien have each acquired ordinary shares in the company through its Share Incentive Plan. The purchases, administered by Equiniti Share Plan Trustees, inv...
Business Operations and StrategyM&A Transactions
Centrica Raises Over £80m From Sale of European Energy Solutions Units
Positive
Feb 9, 2026
Centrica has completed the sale of its non-core European energy solutions businesses in Italy, the Netherlands and Hungary, as well as its Panoramic Power unit, generating proceeds of more than £80 million. The Italian and Dutch operations ha...
Regulatory Filings and Compliance
Centrica Confirms Total Voting Rights and Share Capital Structure
Neutral
Feb 2, 2026
Centrica plc has confirmed that as of 31 January 2026 its issued share capital totals 5,064,902,964 ordinary shares, of which 460,040,495 are held in treasury. This leaves 4,604,862,469 shares in circulation carrying one vote per share, a figure t...
Other
Centrica Non-Executive Directors Increase Holdings Through Share Purchase Agreements
Positive
Jan 26, 2026
Centrica has disclosed that non-executive directors Philippe Boisseau and Sue Whalley have acquired ordinary shares in the company through pre-agreed Share Purchase Agreements executed via Equiniti Financial Services. On 26 January 2026, Boisseau ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.